We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
102
Increased
2,573
Reduced
1,196
Closed
71
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
Nexalin Technology
NXL
$4.66M
| $41.8K | ﹤0.01% |
4,218
| – | – |
2026 Q1
1 quarter
|
|
3952
LiqTech
LIQT
$17M
| $41.8K | ﹤0.01% |
49,175
| – | – |
2026 Q1
1 quarter
|
|
3953
TransCode Therapeutics
RNAZ
$26.8M
| $40.6K | ﹤0.01% |
6,545
| – | – |
2026 Q1
1 quarter
|
|
3954
Amesite
AMST
$6.22M
| $40.2K | ﹤0.01% |
30,201
| – | – |
2026 Q1
1 quarter
|
|
3955
Nauticus Robotics
KITT
$1.99M
| $39.3K | ﹤0.01% |
5,324
| – | – |
2026 Q1
1 quarter
|
|
3956
ENDRA Life Sciences
NDRA
$9.04M
| $39.1K | ﹤0.01% |
7,339
+4,523
| +161% | +$23K |
2026 Q1
1 quarter
|
|
3957
SiNtx Technologies
SINT
$14.9M
| $39.1K | ﹤0.01% |
20,905
| – | – |
2026 Q1
1 quarter
|
|
3958
Cemtrex
CETX
$3.48M
| $38.9K | ﹤0.01% |
12,790
+8,465
| +196% | +$69.4K |
2026 Q1
1 quarter
|
|
|
PARA
3959
Banzai International
PARA
$2.38M
| $38.2K | ﹤0.01% |
12,663
| – | – |
2026 Q1
1 quarter
|
|
|
BCAB
3960
DELISTED
BIOATLA INC
BCAB
| $37.9K | ﹤0.01% |
9,164
-23,821
| -72% | -$101K |
2026 Q1
1 quarter
|
|
|
GRI
3961
GRI Bio
GRI
$4.33M
| $37.8K | ﹤0.01% |
+21,368
| New | +$47.3K |
2026 Q2
0 quarters
|
|
3962
Eterna Therapeutics
ERNA
$3.45M
| $37.8K | ﹤0.01% |
5,684
+4,624
| +436% | +$32.9K |
2026 Q1
1 quarter
|
|
|
NWTG
3963
Newton Golf Co
NWTG
$6.73M
| $37.6K | ﹤0.01% |
44,732
| – | – |
2026 Q1
1 quarter
|
|
3964
Xenetic Biosciences
XBIO
$5.25M
| $36.9K | ﹤0.01% |
12,681
+5,950
| +88% | +$18.4K |
2026 Q1
1 quarter
|
|
3965
Clean Energy Technologies
CETY
$11.8M
| $35.8K | ﹤0.01% |
42,360
+32,345
| +323% | +$26K |
2026 Q1
1 quarter
|
|
|
RIME
3966
Algorhythm Holdings
RIME
$3.44M
| $34.4K | ﹤0.01% |
60,170
+6,081
| +11% | +$5.09K |
2026 Q1
1 quarter
|
|
|
MEDS
3967
DataMeds AI
MEDS
$12M
| $34.4K | ﹤0.01% |
11,085
-1,000
| -8% | -$4.92K |
2026 Q1
1 quarter
|
|
3968
Reborn Coffee
REBN
$17.4M
| $34.3K | ﹤0.01% |
22,709
| – | – |
2026 Q1
1 quarter
|
|
3969
DSS Inc
DSS
$6.53M
| $34.2K | ﹤0.01% |
58,032
| – | – |
2026 Q1
1 quarter
|
|
3970
Hydrofarm Holdings
HYFM
$4.87M
| $33.7K | ﹤0.01% |
39,683
| – | – |
2026 Q1
1 quarter
|
|
3971
CNS Pharmaceuticals
CNSP
$7.67M
| $33.4K | ﹤0.01% |
+6,993
| New | +$29.4K |
2026 Q2
0 quarters
|
|
|
CABR
3972
Caring Brands
CABR
$12.1M
| $32.4K | ﹤0.01% |
26,155
+8,904
| +52% | +$9.99K |
2026 Q1
1 quarter
|
|
3973
BT Brands
BTBD
$11.2M
| $32.3K | ﹤0.01% |
30,218
| – | – |
2026 Q1
1 quarter
|
|
3974
Cosmos Holdings
COSM
$38.1M
| $32.2K | ﹤0.01% |
173,966
+33,959
| +24% | +$9.86K |
2026 Q1
1 quarter
|
|
3975
Soligenix
SNGX
$7.85M
| $32.1K | ﹤0.01% |
81,005
+22,605
| +39% | +$15.2K |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.2%. Vanguard Capital Management opened 102 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 102 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.